Pharmaceutical companies from across the globe are racing to develop COVID-19 vaccines. Reuters reported that, as of August, there were more than 200 vaccine candidates in development globally, including more than 20 in human trials. In Indonesia, a potential vaccine developed by China-based biopharmaceutical company Sinovac Biotech entered the phase three clinical trials in August.  Bambang Heriyanto, corporate secretary of state-owned pharmaceutical holding company PT Bio Farma, said on Monday that, as of Oct. 16, 1,620 volunteers had received the first injection of the potential COVID-19 vaccine, 1,074 volunteers had received the second injection and 671 volunteers had undergone blood tests after receiving the second injection. With all eyes on COVID-19 vaccine, the National COVID-19 task force experts team coordinator and spokesperson Wiku Adisasmito tried to explain...